Lawrence Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lawrence Lin has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Christopher Y. Chew
Skin Health Institute Melbourne Victoria Australia
3 shared publications - Zhao Feng Liu
School of Medicine Monash University Melbourne Victoria Australia
2 shared publications - Alysha Vuong
Royal Adelaide Hospital Adelaide South Australia Australia
1 shared publication Emma Nyhof
Monash Doctors Workforce, Monash Health, Clayton, Victoria, Australia
1 shared publication- Firdavis Xireaili
Faculty of Medicine, Nursing and Health Sciences Monash University Melbourne Victoria Australia
1 shared publication Jade Stevens
Monash Doctors Workforce, Monash Health, Clayton, Victoria, Australia
1 shared publication
Latest Publications
- Open Access
- 5 October 2026
- Published by Wiley in JEADV Clinical Practice
Subcorneal Pustular Dermatosis, a Systematic Review and Pooled Analysis of a Rare and Underdiagnosed Disease
Background: Subcorneal pustular dermatosis (SPD), or Sneddon–Wilkinson disease, is a rare, relapsing pustular skin condition of unknown cause, characterised by subcorneal pustules. Objectives: To summarise the demographic, clinical, histopathological, management and disease course of SPD. Methods: A systematic review was conducted following PRISMA guidelines including all peer‐reviewed, English‐language studies reporting one or more SPD cases. Results: A total of 169 studies (17 case series, 152 case reports) and 205 patients were identified. The median age at diagnosis was 50 years, with a female‐to‐male ratio of 1.77:1. Over two‐thirds of patients had no comorbidities. Monoclonal gammopathy of unknown significance (MGUS) was the most common comorbidity (9.8%), followed by connective tissue disease (7.3%). Clinical pustules were observed in 92.3% of patients, most commonly affecting the trunk (75.1%), limbs (62%), axilla (44.4%) and groin (36.1%). Pruritus was the most common symptom (44.9%), with pain, burning, or irritation occurring in 16.3%. The median time to diagnosis in cases presenting with rash only was 3 years. A precipitant was identified in 22.9% of cases, including infections, flare of underlying condition, or medications such as calcium channel blockers, TNF‐α inhibitors, and antibiotics. In patients who had histopathological findings reported, subcorneal pustules and perivascular infiltrate most common. Dapsone was the most frequently used treatment (133/189, 70.4%), achieving complete response in 33.8%. Topical and systemic corticosteroids achieved complete responses in 22.5% and 29.6%, respectively. Biologics, mostly TNF‐α inhibitors, were used in 11.6%, with complete and partial responses in 63.6% and 27.3%. Limitations: The review's findings are limited by a limited sample size of heterogeneous, observational data, which can be prone to publication bias, so conclusions on SPD's clinical features and treatment efficacy should be interpreted cautiously pending larger, controlled studies. Conclusions: SPD remains a diagnostic and therapeutic challenge, with frequent delays and limited effectiveness of current treatments. These findings underscore the urgent need for prospective studies and targeted therapies to improve outcomes in this rare dermatosis. Systematic Review Registration: PROSPERO CRD42022344461.
- 5 October 2026
- Published by Wiley in JEADV Clinical Practice
Open AccessSubcorneal Pustular Dermatosis, a Systematic Review and Pooled Analysis of a Rare and Underdiagnosed Disease
Background: Subcorneal pustular dermatosis (SPD), or Sneddon–Wilkinson disease, is a rare, relapsing pustular skin condition of unknown cause, characterised by subcorneal pustules. Objectives: To summarise the demographic, clinical, histopathological, management and disease course of SPD. Methods: A systematic review was conducted following PRISMA guidelines including all peer‐reviewed, English‐language studies reporting one or more SPD cases. Results: A total of 169 studies (17 case series, 152 case reports) and 205 patients were identified. The median age at diagnosis was 50 years, with a female‐to‐male ratio of 1.77:1. Over two‐thirds of patients had no comorbidities. Monoclonal gammopathy of unknown significance (MGUS) was the most common comorbidity (9.8%), followed by connective tissue disease (7.3%). Clinical pustules were observed in 92.3% of patients, most commonly affecting the trunk (75.1%), limbs (62%), axilla (44.4%) and groin (36.1%). Pruritus was the most common symptom (44.9%), with pain, burning, or irritation occurring in 16.3%. The median time to diagnosis in cases presenting with rash only was 3 years. A precipitant was identified in 22.9% of cases, including infections, flare of underlying condition, or medications such as calcium channel blockers, TNF‐α inhibitors, and antibiotics. In patients who had histopathological findings reported, subcorneal pustules and perivascular infiltrate most common. Dapsone was the most frequently used treatment (133/189, 70.4%), achieving complete response in 33.8%. Topical and systemic corticosteroids achieved complete responses in 22.5% and 29.6%, respectively. Biologics, mostly TNF‐α inhibitors, were used in 11.6%, with complete and partial responses in 63.6% and 27.3%. Limitations: The review's findings are limited by a limited sample size of heterogeneous, observational data, which can be prone to publication bias, so conclusions on SPD's clinical features and treatment efficacy should be interpreted cautiously pending larger, controlled studies. Conclusions: SPD remains a diagnostic and therapeutic challenge, with frequent delays and limited effectiveness of current treatments. These findings underscore the urgent need for prospective studies and targeted therapies to improve outcomes in this rare dermatosis. Systematic Review Registration: PROSPERO CRD42022344461.
- 21 January 2026
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 39 (1) , e70065
Excimer 308‐Nm Light in the Combination Treatment of Vitiligo: A Systematic Review and Network Meta‐Analysis
Excimer 308‐nm light is often used for vitiligo treatment in combination with adjuvants. We aimed to evaluate the efficacy of these combination therapies. We searched MEDLINE, Embase and the Cochrane Library from inception to November 2024. All randomised trials reporting efficacy outcomes for vitiligo patients treated with excimer 308‐nm light were included. Primary outcomes were achieving ≥ 50%, ≥ 75% and 100% skin repigmentation. Pairwise comparisons of treatment repigmentation were summarised as risk ratios (RRs) with 95% confidence intervals (CIs) and a frequentist, random‐effects network meta‐analysis with a graph‐theoretical approach was used to generate summary estimates. Thirty‐eight studies involving 1841 participants were included. Excimer 308‐nm light with topical calcineurin inhibitors or topical corticosteroids significantly improved repigmentation outcomes compared to excimer monotherapy with ≥ 50% (RR 1.47, 95% CI 1.19–1.81; RR 1.65, 95% CI 1.32–2.06) and ≥ 100% repigmentation (RR 1.60, 95% CI 1.03–2.49; RR 2.31, 95% CI 1.50–3.56) respectively. Excimer in combination with topical antioxidants (RR 43.00, 95% CI 2.68–688.68), intramuscular corticosteroid (RR 1.76, 95% CI 1.13–2.74) and platelet rich plasma (RR 1.76, 95% CI 1.32–2.35) enhanced ≥ 50% repigmentation. These findings highlight the value of combination therapy with excimer light as a useful option in the management of vitiligo.
- 21 January 2026
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 39 (1) , e70065
Excimer 308‐Nm Light in the Combination Treatment of Vitiligo: A Systematic Review and Network Meta‐Analysis
Excimer 308‐nm light is often used for vitiligo treatment in combination with adjuvants. We aimed to evaluate the efficacy of these combination therapies. We searched MEDLINE, Embase and the Cochrane Library from inception to November 2024. All randomised trials reporting efficacy outcomes for vitiligo patients treated with excimer 308‐nm light were included. Primary outcomes were achieving ≥ 50%, ≥ 75% and 100% skin repigmentation. Pairwise comparisons of treatment repigmentation were summarised as risk ratios (RRs) with 95% confidence intervals (CIs) and a frequentist, random‐effects network meta‐analysis with a graph‐theoretical approach was used to generate summary estimates. Thirty‐eight studies involving 1841 participants were included. Excimer 308‐nm light with topical calcineurin inhibitors or topical corticosteroids significantly improved repigmentation outcomes compared to excimer monotherapy with ≥ 50% (RR 1.47, 95% CI 1.19–1.81; RR 1.65, 95% CI 1.32–2.06) and ≥ 100% repigmentation (RR 1.60, 95% CI 1.03–2.49; RR 2.31, 95% CI 1.50–3.56) respectively. Excimer in combination with topical antioxidants (RR 43.00, 95% CI 2.68–688.68), intramuscular corticosteroid (RR 1.76, 95% CI 1.13–2.74) and platelet rich plasma (RR 1.76, 95% CI 1.32–2.35) enhanced ≥ 50% repigmentation. These findings highlight the value of combination therapy with excimer light as a useful option in the management of vitiligo.
- 5 October 2023
- Published by BMJ in BMJ Leader
- Vol. 8 (2) , 134-141
Medical Specialty Interest Survey (MSIS): understanding career interest and specialty training in commencing Australian medical interns
Aim: To assess specialisation interests in commencing interns and create a standardised survey to aid medical schools, supervisors and health services in quantifying, understanding and supporting medical career development to improve medical workforce planning. Method: The Medical Specialty Interest Survey (MSIS) cross-sectional study was used. Incoming interns at a multisite tertiary hospital network in Melbourne, Australia rated their desire to pursue each specialty as a career using a Likert scale (1–5). 47 Medical Board of Australia Medical Specialties were included in the survey. Results: Completion rate was 123 of 124 (99.2%). The overall mean desirability was 2.62, suggesting on average more specialties were deemed less preferred. Critical care specialties were most popular, while surgical specialties had least interest. Gastroenterology and cardiology were most popular among internal medicine specialties. General practice had low correlation with other specialties (Pearson correlation mean R coefficient 0.106 compared with overall mean 0.208), suggesting interns interested in general practice exhibit less interest in other specialties, and interest in specialisation confers low interest in general practice. Psychiatry had the lowest mean R coefficient of 0.088. Conclusions: The MSIS quantifies relative interest in 47 medical specialties and specialty interest correlations among final-year medical students/incoming interns. The MSIS may be a tool for medical schools, healthcare services and government agencies to better understand the career interest among medical students and pre-vocational doctors and therefore improve doctor retention and well-being.
- 5 October 2023
- Published by BMJ in BMJ Leader
- Vol. 8 (2) , 134-141
Medical Specialty Interest Survey (MSIS): understanding career interest and specialty training in commencing Australian medical interns
Aim: To assess specialisation interests in commencing interns and create a standardised survey to aid medical schools, supervisors and health services in quantifying, understanding and supporting medical career development to improve medical workforce planning. Method: The Medical Specialty Interest Survey (MSIS) cross-sectional study was used. Incoming interns at a multisite tertiary hospital network in Melbourne, Australia rated their desire to pursue each specialty as a career using a Likert scale (1–5). 47 Medical Board of Australia Medical Specialties were included in the survey. Results: Completion rate was 123 of 124 (99.2%). The overall mean desirability was 2.62, suggesting on average more specialties were deemed less preferred. Critical care specialties were most popular, while surgical specialties had least interest. Gastroenterology and cardiology were most popular among internal medicine specialties. General practice had low correlation with other specialties (Pearson correlation mean R coefficient 0.106 compared with overall mean 0.208), suggesting interns interested in general practice exhibit less interest in other specialties, and interest in specialisation confers low interest in general practice. Psychiatry had the lowest mean R coefficient of 0.088. Conclusions: The MSIS quantifies relative interest in 47 medical specialties and specialty interest correlations among final-year medical students/incoming interns. The MSIS may be a tool for medical schools, healthcare services and government agencies to better understand the career interest among medical students and pre-vocational doctors and therefore improve doctor retention and well-being.